POC PLATFORM AND TECHNOLOGY MARKET ANALYSIS

POC Platform and Technology Market, by Technology (Lateral Flow Based Assays (Colloidal Gold Label, Colored Latex Particle Label, Paramagnetic Monodisperse Latexes, and Fluorescence Immunoassay), Enzyme Labels, Microfluidics, Biochips, Biosensors, Medical MEMS, Agglutination, Solid Phase, Lab-on-a-chip, and Chemiluminescence Based Systems), by Application (Diagnostic Testing & Monitoring and Drug Development & Quality Testing), by End User (Hospitals, Clinics, Laboratories, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Feb 2022
Code : CMI1501
Pages :202
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

Global POC Platform and Technology Market Restraint

The point-of-care technologies employs numerous methodologies that vary in terms of interfaces to test methods that are actually employed in centralized laboratories. Comparison among the results exhibited by POC tests and manual laboratory tests often show variations that questions the accuracy and reliability of point-of-care platform and technology. The calibration of these tests also vary from one device to other. Thus, just as the test results may not be consistent from one laboratory to another, there may be variation in the data obtained through the use of different devices making it difficult for the healthcare professionals to make an important clinical decision. Moreover, transportation of biomaterials in cold chain is expensive in the resource-constrained settings, thus significantly increasing the assay cost and decreasing the adoption of the POC tests, as cold chain storage rarely practical in the under developed countries such sub-Saharan Africa. Thus, the limited shelf life of the reagents is a prominent restraining factor.